UNIVERSE PHARMACEUTICALS INC's ticker is UPC and the CUSIP is G9442G104. A total of 4 filers reported holding UNIVERSE PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12 | -42.9% | 39,329 | 0.0% | 0.00% | – |
| Q1 2023 | $21 | -61.8% | 39,329 | 0.0% | 0.00% | – |
| Q4 2022 | $55 | -99.2% | 39,329 | +195.7% | 0.00% | – |
| Q3 2022 | $7,000 | -12.5% | 13,299 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -50.0% | 13,299 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | -23.8% | 13,299 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | – | 13,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS Group AG | 919 | $3,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| BANK OF MONTREAL /CAN/ | 40,000 | $148,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 18 | $0 | 0.00% |